163 related articles for article (PubMed ID: 10230460)
1. Interaction of paclitaxel (Taxol) and irradiation. In-vitro differences between tumor and fibroblastic cells.
Cordes N; Plasswilm L; Sauer R
Strahlenther Onkol; 1999 Apr; 175(4):175-81. PubMed ID: 10230460
[TBL] [Abstract][Full Text] [Related]
2. Cell line and schedule-dependent cytotoxicity of paclitaxel (Taxol): role of the solvent Cremophor EL/ethanol.
Cordes N; Plasswilm L
Anticancer Res; 1998; 18(3A):1851-7. PubMed ID: 9673415
[TBL] [Abstract][Full Text] [Related]
3. Schedule-dependent interaction of paclitaxel (Taxol) and irradiation in vitro.
Plasswilm L; Cordes N; Sauer R
Radiat Oncol Investig; 1998; 6(1):10-7. PubMed ID: 9503485
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of fractionated paclitaxel (Taxol) administration in vitro.
Plasswilm L; Cordes N; Fietkau R; Sauer R
Strahlenther Onkol; 1998 Jan; 174(1):37-42. PubMed ID: 9463563
[TBL] [Abstract][Full Text] [Related]
5. Murine intestinal crypt survival after combined taxol plus radiation exposure.
Lojun SL; Sigdestad CP; Connor AM; Spanos WJ; Bosscher JR
Gynecol Oncol; 1996 Nov; 63(2):180-3. PubMed ID: 8910624
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
Gorodetsky R; Levdansky L; Ringel I; Vexler A
Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
[TBL] [Abstract][Full Text] [Related]
7. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol).
Liebmann J; Cook JA; Fisher J; Teague D; Mitchell JB
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):559-64. PubMed ID: 7911794
[TBL] [Abstract][Full Text] [Related]
8. Differential activity of Cremophor EL and paclitaxel in patients' tumor cells and human carcinoma cell lines in vitro.
Csóka K; Dhar S; Fridborg H; Larsson R; Nygren P
Cancer; 1997 Mar; 79(6):1225-33. PubMed ID: 9070502
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
[TBL] [Abstract][Full Text] [Related]
10. [Radiosensitization of paclitaxel combined with radiation on nasopharygneal carcinoma cells (CNE-I) in vitro].
Yuan ZY; Yang WZ; Jin J; Gao L; Liu XF; Xu GZ
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):649-52. PubMed ID: 18246791
[TBL] [Abstract][Full Text] [Related]
11. Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system.
Attawia MA; Borden MD; Herbert KM; Katti DS; Asrari F; Uhrich KE; Laurencin CT
J Control Release; 2001 Apr; 71(2):193-202. PubMed ID: 11274751
[TBL] [Abstract][Full Text] [Related]
12. The effect of paclitaxel on the radiosensitivity of gynecological tumor cells.
Rave-Fränk M; Meden H; Jäschke A; Tänzer A; Boghun O; Fietkau R
Strahlenther Onkol; 1997 May; 173(5):281-6. PubMed ID: 9176559
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of topotecan and irradiation on the survival and the induction of chromosome aberrations in vitro.
Rave-Fränk M; Glomme S; Hertig J; Weiss E; Pradier O; Hess CF; Virsik-Köpp P; Schmidberger H
Strahlenther Onkol; 2002 Sep; 178(9):497-503. PubMed ID: 12426836
[TBL] [Abstract][Full Text] [Related]
14. Taxol as a radiation sensitizer: a flow cytometric study.
Steren A; Sevin BU; Perras J; Ramos R; Angioli R; Nguyen H; Koechli O; Averette HE
Gynecol Oncol; 1993 Jul; 50(1):89-93. PubMed ID: 8102348
[TBL] [Abstract][Full Text] [Related]
15. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696
[TBL] [Abstract][Full Text] [Related]
16. Radiochemotherapy with paclitaxel: synchronization effects and the role of p53.
Wenz F; Greiner S; Germa F; Mayer K; Latz D; Weber KJ
Strahlenther Onkol; 1999 Oct; 175 Suppl 3():2-6. PubMed ID: 10554637
[TBL] [Abstract][Full Text] [Related]
17. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines.
Stromberg JS; Lee YJ; Armour EP; Martinez AA; Corry PM
Cancer; 1995 May; 75(9):2262-8. PubMed ID: 7712434
[TBL] [Abstract][Full Text] [Related]
18. Proliferation and clonal survival of human lung cancer cells treated with fractionated irradiation in combination with paclitaxel.
van Rijn J; van den Berg J; Meijer OW
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):635-9. PubMed ID: 7558953
[TBL] [Abstract][Full Text] [Related]
19. Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro.
Hahn SM; Liebmann JE; Cook J; Fisher J; Goldspiel B; Venzon D; Mitchell JB; Kaufman D
Cancer; 1993 Nov; 72(9):2705-11. PubMed ID: 8104682
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.
Hoffmann W; Rodemann HP; Belka C; Budach W; Schmidberger H; Bochtler H; Heinrich V; Bamberg M
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-72-S2-77. PubMed ID: 9045342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
